These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25833874)

  • 21. The neurobiological underpinnings of risk and conversion in relatives of patients with schizophrenia.
    Whalley HC; Harris JC; Lawrie SM
    Int Rev Psychiatry; 2007 Aug; 19(4):383-97. PubMed ID: 17671871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder.
    Hulshoff Pol HE; van Baal GC; Schnack HG; Brans RG; van der Schot AC; Brouwer RM; van Haren NE; Lepage C; Collins DL; Evans AC; Boomsma DI; Nolen W; Kahn RS
    Arch Gen Psychiatry; 2012 Apr; 69(4):349-59. PubMed ID: 22474104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regarding brain structure characteristics in intellectually superior schizophrenia.
    Docherty AR
    Psychiatry Res; 2015 Sep; 233(3):496. PubMed ID: 26319294
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of self-complexity in reducing harmful insight among persons with schizophrenia. Theoretical and therapeutic implications.
    Martens WH
    Am J Psychother; 2009; 63(1):53-68. PubMed ID: 19425334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired verbal source monitoring in schizophrenia: an intermediate trait vulnerability marker?
    Brunelin J; d'Amato T; Brun P; Bediou B; Kallel L; Senn M; Poulet E; Saoud M
    Schizophr Res; 2007 Jan; 89(1-3):287-92. PubMed ID: 17029909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
    Karch S; Leicht G; Giegling I; Lutz J; Kunz J; Buselmeier M; Hey P; Spörl A; Jäger L; Meindl T; Pogarell O; Möller HJ; Hegerl U; Rujescu D; Mulert C
    J Psychiatr Res; 2009 Oct; 43(15):1185-94. PubMed ID: 19426993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intrinsic motivation: a new direction of understanding and treatment of schizophrenia?].
    Wertman M; Grunhaus L; Israeli D
    Harefuah; 2013 Sep; 152(9):552-5, 562. PubMed ID: 24364098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain-behaviour relationships in people at high genetic risk of schizophrenia.
    Lymer GK; Job DE; William T; Moorhead J; McIntosh AM; Owens DG; Johnstone EC; Lawrie SM
    Neuroimage; 2006 Oct; 33(1):275-85. PubMed ID: 16926102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mental health. Taking back control.
    Favrod J
    Nurs Times; 1993 Aug 25-31; 89(34):68-70. PubMed ID: 8139949
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathophysiology of early onset schizophrenia.
    Kyriakopoulos M; Frangou S
    Int Rev Psychiatry; 2007 Aug; 19(4):315-24. PubMed ID: 17671865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The striatum and dopamine: a crossroad of risk for schizophrenia.
    Horga G; Abi-Dargham A
    JAMA Psychiatry; 2014 May; 71(5):489-91. PubMed ID: 24622875
    [No Abstract]   [Full Text] [Related]  

  • 32. Providing schizophrenic patients with a concept of illness. An essential element of therapy.
    Süllwold L; Herrlich J
    Br J Psychiatry Suppl; 1992 Oct; (18):129-32. PubMed ID: 1389036
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of American and Japanese schizophrenic patients elicited by the Rorschach technique and demographic data.
    Suzuki A; Peters L; Weisbender L; Gillespie J
    Int J Soc Psychiatry; 1987; 33(1):50-5. PubMed ID: 3583606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential bias in meta-analyses of effect sizes in imaging genetics.
    Paulus FM; Krach S; Albrecht AG; Jansen A
    Schizophr Bull; 2013 May; 39(3):501-3. PubMed ID: 23474966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grey matter changes over time in high risk subjects developing schizophrenia.
    Job DE; Whalley HC; Johnstone EC; Lawrie SM
    Neuroimage; 2005 May; 25(4):1023-30. PubMed ID: 15850721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight controlled for cognition in deficit and nondeficit schizophrenia.
    Dantas CR; Barros BR; Fernandes PT; Li LM; Banzato CE
    Schizophr Res; 2011 May; 128(1-3):124-6. PubMed ID: 21353484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcortical structure alterations impact language processing in individuals with schizophrenia and those at high genetic risk.
    Li X; Black M; Xia S; Zhan C; Bertisch HC; Branch CA; DeLisi LE
    Schizophr Res; 2015 Dec; 169(1-3):76-82. PubMed ID: 26386898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the delusional experience of controlling other persons in acute schizophrenics.
    Nakaya M
    Psychopathology; 1993; 26(5-6):279-85. PubMed ID: 8190848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients.
    Lennertz L; Rujescu D; Wagner M; Frommann I; Schulze-Rauschenbach S; Schuhmacher A; Landsberg MW; Franke P; Möller HJ; Wölwer W; Gaebel W; Häfner H; Maier W; Mössner R
    Neuropsychobiology; 2011; 63(3):131-6. PubMed ID: 21228604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connecting brain structure and function in schizophrenia.
    Tregellas J
    Am J Psychiatry; 2009 Feb; 166(2):134-6. PubMed ID: 19188288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.